.
Angewandte
Communications
Kawamura, M. Sugiura, Synlett 2001, 983; f) S. Kanemasa, K. Ito,
h) B.-J. Li, L. Jiang, M. Liu, Y.-C. Chen, L.-S. Ding, Y. Wu,
Synlett 2005, 603; i) S. J. K. Sauerland, E. Kiljunen, A. M. P.
5411; k) M. Kawatsura, Y. Komatsu, M. Yamamoto, S. Hayase, T.
drug: d) J. Krapcho, E. R. Spitzmiller, C. F. Turk, J. Med. Chem.
TA-993, an anti-platelet agent: f) H. Narita, M. Kaburaki, H.
GW-577, under preclinical study for treatment of lipoprotein
disorders: g) L. E. Brieaddy, A. L. Handlon, G. L. Hodgson, Jr.,
EP792268, 1997; WO9616051, 1996; NF 49, an agonist of
constitutive androstane receptor 3: h) L. E. Anderson, A. M.
[12] For recent reviews on cooperative catalysis, see: Lewis acid/
Brønsted base a) M. Shibasaki, N. Yoshikawa, Chem. Rev. 2002,
102, 2187; b) N. Kumagai, M. Shibasaki, Angew. Chem. 2011,
123, 4856; Angew. Chem. Int. Ed. 2011, 50, 4760; Lewis acid/
Lewis base: c) M. Kanai, N. Kato, E. Ichikawa, M. Shibasaki,
Synlett 2005, 1491; d) D. H. Paull, C. J. Abraham, M. T. Scerba,
E. Alden-Da orth, T. Lectka, Acc. Chem. Res. 2008, 41, 655;
Lewis acid/Brønsted acid and Lewis acid/Lewis acid: e) H.
Yamamoto, K. Futatsugi, Angew. Chem. 2005, 117, 1958; Angew.
Chem. Int. Ed. 2005, 44, 1924; f) H. Yamamoto, K. Futatsugi,
Acid Catalysis in Modern Organic Synthesis (Eds.: H. Yama-
moto, K. Ishihara) Wiley-VCH, Weinheim, 2008.
[8] Conjugate addition of thiols to a-substituted acrylate derivatives
coupled with catalytic asymmetric protonation: a) A. Kumar,
Synlett 2012, 314.
[13] No products derived from the conjugate addition at the nitrogen
atom were detected.
[14] The absolute configuration of the product was determined after
converting into the reported compounds. See the Supporting
Information for details.
[9] a) A. Nudelman, The Chemistry of Optically Active Sulfur
Compounds, Gordon and Breach, New York, 1984; b) Sulphur-
Containing Drugs and Related Organic Compounds (Ed.: L. A.
Damani), Wiley, New York, 1989; c) Organosulfur Chemistry in
Asymmetric Synthesis (Eds.: T. Toru, C. Bolm), Wiley-VCH,
Weinheim, 2008; d) Chiral Sulfur Ligands: Asymmetric Catalysis
(Ed.: H. Pellissier), Royal Society of Chemistry, Cambridge,
[10] For reviews on synthesis and applications of 1,5-benzothiaze-
pines, see: a) A. Lꢁvai, J. Heterocycl. Chem. 2000, 37, 199; b) A.
Lꢁvai, A. Kiss-Szikszai, ARKIVOC 2008, 65; c) J. B. Bariwal,
K. D. Upadhyay, A. T. Manvar, J. C. Trivedi, J. S. Singh, K. S.
[11] Quetiapine, a clinically used for the treatment of schizophrenia:
1970, 59, 964; b) J. Hopenwasser, A. Mozayani, T. J. Danielson,
A. Harbin, H. S. Narula, D. H. Posey, P. W. Shrode, S. K. Wilson,
R. Li, L. A. Sanchez, J. Anal. Toxicol. 2004, 28, 264; diltiazem is
a clinically used Ca2+ channel blocker for the treatment of
hypertension: c) T. Nagao, M. Sato, H. Nakajima, A. Kiyomoto,
[15] For the construction of enantioenriched 1,5-benzothiazepin-
4(5H)-one from catalytic asymmetric protonation coupled with
the conjugate addition of 2-aminothiophenol, see Ref. [8e].
[16] For acid-catalyzed lactam formation for the synthesis of 1,5-
benzothiazepine-4(5H)-ones, see: a) S. Yamada, I. Tsujioka, T.
[17] For the synthesis of the racemate of thiazesim, see
Ref. [11d,e,16b].
[18] For the synthesis of the racemate and optical resolution of
thiazesim, see: a) J. Krapcho, C. F. Turk, J. J. Piala, J. Med. Chem.
[19] For the enantioselective synthesis of thiazesim by a chemo-
enzymatic reaction, see: a) S. Y. Dike, D. H. Ner, A. Kumar,
S. Y. Dike, Ind. J. Chem. Sect. B. 1992, 31, 803.
[20] For a formal enantioselective synthesis of thiazesim by catalytic
asymmetric conjugate addition of thiophenol to alkenylisoxa-
zoles, see: Q.-L. Pei, H.-W. Sun, Z.-J. Wu, X.-L. Du, X.-M.
4
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2012, 51, 1 – 5
These are not the final page numbers!